2023
The seventh CCRC takes place for the first time in Halifax, Nova Scotia and is CCRA’s first hybrid conference. There are 872 registrants and 673 abstract submissions.
The Patient Involvement in Cancer Research Program (PIP), held in conjunction with the CCRC, engages 36 patient partners, 13 attending in-person and 23 virtually.
The CCRA research investment data is refreshed to year 2021.
Open Call for Research Proposals for BioCanRx
BioCanRx, Canada’s Immunotherapy Network, is launching its first Open Call for Research Proposals, made possible by funding from the Strategic Science Fund. By funding the selected proposals, BioCanRx will increase support for multi-disci... Read More »
BioCanRx, Canada’s Immunotherapy Network, is launching its first Open Call for Research Proposals, made possible by funding from the Strategic Science Fund. By funding the selected proposals, BioCanRx will increase support for multi-disci... Read More »
Article Published on PIP Grant Adjudication
Today in the Journal of Patient Experience, an article on the 2021 inaugural PIP grant adjudication was published by the 2021 PIP Working Group. Thanks to our PIP supporters!
Acc... Read More »
Today in the Journal of Patient Experience, an article on the 2021 inaugural PIP grant adjudication was published by the 2021 PIP Working Group. Thanks to our PIP supporters!
Acc... Read More »